Clinical study of ghrelin administration on diabetic neuropathy
Phase 1
- Conditions
- type2 diabetes mellitus
- Registration Number
- JPRN-UMIN000001707
- Lead Sponsor
- eurology, Respirology, Endocrinology and Metabolism, Miyazaki Medical College, University of Miyazaki
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
Insulin treatment. Severe liver or renal dysfunction. Severe heart diseases. Proliferative diabetic retinopathy. Medication with epalrestat, anti-eplepsy drugs, or mexiletine. Pregnant women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of diabetic neuropathy. Changes of glucose metabolism and appetite.
- Secondary Outcome Measures
Name Time Method Insulin secretion capacity.